Effect of exenatide twice daily and dapagliflozin alone and in combination on markers of kidney function in obese patients with type 2 diabetes: a prespecified secondary analysis of a randomized controlled clinical trial
2019 ◽
Vol 28
◽
pp. 177-182
◽
2004 ◽
Vol 21
(11)
◽
pp. 1200-1203
◽
2015 ◽
Vol 34
(4)
◽
pp. 281-289
◽
2009 ◽
Vol 11
(7)
◽
pp. 700-708
◽
2012 ◽
Vol 3
(4)
◽
pp. 276-283
◽
2020 ◽
Vol 25
(3)
◽
pp. 224
◽